Hudson Bay Capital Management
TERN

Hudson Bay Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Hudson Bay Capital Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-360,878
Closed -$19M – 1690
2026
Q1 		$19M Buy
360,878
+279,844
+345% +$11.5M 0.07% 202
2025
Q4 		$3.27M Buy
+81,034
New +$1.87M 0.01% 608

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hudson Bay Capital Management's TERN Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 360,878 shares — an estimated $19M sold.

Hudson Bay Capital Management first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $19M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 360,878 Terns Pharmaceuticals shares in Q2 2026, an estimated $19M.
  • Hudson Bay Capital Management first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Hudson Bay Capital Management's Terns Pharmaceuticals position peaked at $19M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.